biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sinbobon May 24, 2013 11:01am

161 Views

Post# 21436808

RE: RE: RE: RE: RE: RE: RE: One year with Abbott

Wounded Knee!!! Don't you recognize an a 'mazing'', self proclaimed 'professional'' when you see one? Same old nonsense. You and the 'Dr.' are in deep 'poop' now. Yikes!!!! Dr. 'J' better watch where he parks his flambouyant sportster. Those 'out of work' civil servants can be quite vindictive.

The board remains colourful and interesting with pmrider anchoring the credibility portion. Thanks pmrider.

I'm guessing, similar to others here, that the big pharmas will take their time in deliberations with themselves and BTI... with solid news mid summer to early Fall.

Cheers all. Good investing.

Wes, I will inbox you today.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario